Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-03-24Clinical Trial Update: Re-challenge Pembrolizumab Study as a Second or Further Line in Patients With Advanced NSCLC [Phase 2]
Phase II trial evaluates re-challenge with pembrolizumab as second- or later-line therapy in patients with advanced Non-small cell lung canc…
-
CLINICAL_TRIALS trial_result · 2025-03-24Clinical Trial Update: ONO-4538 Study in Patients With Advanced Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial of ONO-4538 (nivolumab) in patients with advanced non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2025-03-21Clinical Trial Update: Phase II Concurrent Durvalumab and Radiotherapy for for Stage III Non-Small Cell Lung Cancer [Phase 2]
A Phase II trial evaluating concurrent durvalumab with radiotherapy for Stage III Non-Small Cell Lung Cancer has completed and results were …
-
CLINICAL_TRIALS trial_result · 2025-03-21Clinical Trial Update: Oral STAT3 Inhibitor, TTI-101, in Patients With Advanced Cancers [Phase 1]
Phase 1 study of the oral STAT3 inhibitor TTI-101 in patients with advanced cancers has completed, with enrollment across multiple tumor typ…
-
CLINICAL_TRIALS trial_result · 2025-03-21Clinical Trial Update: Clinical Trial of YH25448 in Patients with EGFR Mutation Positive Advanced NSCLC [Phase 1, Phase 2]
The document indicates that the Phase 1/2 clinical trial of YH25448 in EGFR mutation-positive advanced non-small cell lung cancer has comple…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-03-21Clinical Trial Update: A Multicenter Clinical Trial of Sputum DNA Testing for Lung Cancer in China
This update reports the completion of a multicenter clinical trial evaluating sputum DNA testing for lung cancer in China, sponsored by Crea…
-
CLINICAL_TRIALS trial_result · 2025-03-21Clinical Trial Update: Abequolixron (RGX-104) and Durvalumab in Lung Cancer [Phase 1]
Phase 1 trial evaluating Abequolixron (RGX-104) in combination with Durvalumab for non-small cell lung cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2025-03-20Clinical Trial Update: Ph1b/2 Dose-Escalation Study of Entinostat With Pembrolizumab in Non-small Cell Lung Cancer (NSCLC) With Expansion Cohorts in NSCLC, Melanoma, and Colorectal Cancer (CRC) [Phase 1, Phase 2]
A Phase 1b/2 dose-escalation trial of entinostat with pembrolizumab in non-small cell lung cancer, with expansion cohorts in melanoma and co…
-
CLINICAL_TRIALS trial_result · 2025-03-20Clinical Trial Update: Study of MCLA-129 in the Treatment of Advanced Non-small Cell Lung Cancer with AGA and MET Amplification. [Phase 2]
A Phase 2 study of MCLA-129 for advanced non-small cell lung cancer with AGA and MET amplification is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2025-03-20Clinical Trial Update: Nous-PEV: a Novel Immunotherapy for Lung Cancer and Melanoma [Phase 1]
Phase 1 study of Nous-PEV for melanoma and non-small cell lung cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-03-19Clinical Trial Update: Relative Bioavailability/Bioequivalence of Different Formulations of Selinexor, the Impact of Hepatic Impairment on Selinexor Pharmacokinetics, Tolerability and Antitumor Activity of Selinexor Combination Treatment [Phase 1, Phase 2]
The update reports on the relative bioavailability/bioequivalence of different selinexor formulations, the impact of hepatic impairment on s…
-
CLINICAL_TRIALS trial_result · 2025-03-19Clinical Trial Update: A Study Assessing Risk Factors for Oral Mucositis/Stomatitis and Ocular Surface Events in NSCLC and Breast Cancer
A completed clinical trial evaluating risk factors for oral mucositis/stomatitis and ocular surface events in patients with advanced/metasta…
-
CLINICAL_TRIALS trial_result · 2025-03-18Clinical Trial Update: A Study of Relatlimab Plus Nivolumab in Combination With Chemotherapy vs. Nivolumab in Combination With Chemotherapy as First Line Treatment for Participants With Stage IV or Recurrent Non-small Cell Lung Cancer (NSCLC) [Phase 2]
Phase 2 clinical trial update comparing relatlimab plus nivolumab with chemotherapy versus nivolumab with chemotherapy as first-line treatme…
-
CLINICAL_TRIALS trial_result · 2025-03-18Clinical Trial Update: A Study of BMS-986442 With Nivolumab With or Without Chemotherapy in Solid Tumors and Non-small Cell Lung Cancer [Phase 1, Phase 2]
Phase 1/2 study of BMS-986442 with nivolumab, with or without chemotherapy, in solid tumors and non-small cell lung cancer has been terminat…
-
CLINICAL_TRIALS trial_result · 2025-03-17Clinical Trial Update: RRx-001 in Lung Cancer, Ovarian Cancer and Neuroendocrine Tumors Prior to Re-administration of Platinum Based Doublet Regimens (QUADRUPLE THREAT) [Phase 2]
A Phase 2 trial (QUADRUPLE THREAT) evaluated RRx-001 in small cell lung cancer, non-small cell lung cancer, neuroendocrine tumors, and epith…
-
CLINICAL_TRIALS trial_result · 2025-03-17Clinical Trial Update: To Compare Efficacy and Safety of CT-P16 and European Union-Approved Avastin as First-Line Treatment for Metastatic or Recurrent Non-Squamous Non-Small Cell Lung Cancer [Phase 3]
Phase 3 trial comparing CT-P16, a bevacizumab biosimilar from Celltrion, with EU-approved Avastin in first-line treatment of metastatic or r…
-
CLINICAL_TRIALS trial_result · 2025-03-17Clinical Trial Update: Tusamitamab Ravtansine (SAR408701) in Combination With Pembrolizumab and Tusamitamab Ravtansine (SAR408701) in Combination With Pembrolizumab and Platinum-based Chemotherapy With or Without Pemetrexed in Patients With NSQ NSCLC [Phase 2]
Phase 2 trial of Tusamitamab Ravtansine (SAR408701) with pembrolizumab, with or without platinum-based chemotherapy with/without pemetrexed,…
-
CLINICAL_TRIALS trial_result · 2025-03-14Clinical Trial Update: SL-279252 (PD1-Fc-OX40L) in Subjects With Advanced Solid Tumors or Lymphomas [Phase 1]
Phase 1 trial evaluating SL-279252, a PD-1-Fc-OX40L fusion protein, in adults with advanced solid tumors or lymphomas has been completed wit…
-
CLINICAL_TRIALS trial_result · 2025-03-14Clinical Trial Update: Volatile Anaesthesia and Perioperative Outcomes Related to Cancer: the VAPOR-C Trial [Phase 3]
The Phase 3 VAPOR-C trial evaluating volatile anesthesia and perioperative outcomes in cancer patients has been terminated, including colon …
-
CLINICAL_TRIALS trial_result · 2025-03-13Clinical Trial Update: Combinations of Cemiplimab (Anti-PD-1 Antibody) and Platinum-based Doublet Chemotherapy in Patients With Lung Cancer [Phase 3]
Phase 3 trial update on combining cemiplimab with platinum-based chemotherapy for non-small cell lung cancer. The study has completed.
-
CLINICAL_TRIALS trial_result · 2025-03-13Clinical Trial Update: Tislelizumab in Addition to BACE in Patients with NSCLC [Phase 2]
Phase 2 trial evaluating adding tislelizumab to the BACE regimen in non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2025-03-13Clinical Trial Update: Study of INCB086550 in Select Solid Tumors [Phase 2]
A Phase 2 trial evaluating INCB086550 across select solid tumors, including non-small cell lung cancer and urothelial carcinoma, was termina…
-
CLINICAL_TRIALS trial_result · 2025-03-13Clinical Trial Update: Phase II Study of Chemotherapy and PD-1 Inhibitor Combination With Autologous CIK Cell Immunotherapy to Treat Lung Cancer [Phase 2]
This is a Phase II clinical trial evaluating a combination of chemotherapy, a PD-1 inhibitor, and autologous CIK cell immunotherapy for meta…
-
CLINICAL_TRIALS trial_result · 2025-03-11Clinical Trial Update: Unresectable Stage IIIA/IIIB Non-small Cell Lung Cancer (NSCLC) [Phase 2]
Phase 2 trial update for unresectable stage IIIA/IIIB non-small cell lung cancer; results have been posted as of March 11, 2025.
-
CLINICAL_TRIALS trial_result · 2025-03-11Clinical Trial Update: Maintenance Chemotherapy With or Without Local Consolidative Therapy in Treating Patients With Stage IV Non-small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating maintenance chemotherapy with or without local consolidative therapy in stage IV non-small cell lung cancer; the st…